These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 14767382

  • 1. TNF inhibitors: a new age in rheumatoid arthritis treatment.
    Anderson DL.
    Am J Nurs; 2004 Feb; 104(2):60-8; quiz 68-9. PubMed ID: 14767382
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors.
    Anderson P, Louie J, Lau A, Broder M.
    Curr Rheumatol Rep; 2005 Mar; 7(1):3-9. PubMed ID: 15760575
    [No Abstract] [Full Text] [Related]

  • 3. TNF-alpha inhibition: the need for a tumor necrosis factor thermostat.
    O'Dell JR.
    Mayo Clin Proc; 2001 Jun; 76(6):573-5. PubMed ID: 11393494
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [TNF targetting therapy for rheumatoid arthritis].
    Takeuchi T.
    Nihon Naika Gakkai Zasshi; 2006 Sep 10; 95(9):1787-94. PubMed ID: 17037316
    [No Abstract] [Full Text] [Related]

  • 6. Which TNF inhibitor for rheumatoid arthritis?
    Med Lett Drugs Ther; 2010 May 17; 52(1338):38-9. PubMed ID: 20467356
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Anti-TNF therapy in rheumatoid arthritis].
    Yakeuchi T, Amano K.
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Feb 17; 27(1):7-15. PubMed ID: 15045810
    [No Abstract] [Full Text] [Related]

  • 9. Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al.
    Neovius M, Askling J.
    Ann Rheum Dis; 2014 Jun 17; 73(6):e32. PubMed ID: 24638970
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
    Bombardieri S, Ferraccioli G, Ferri C, Galeazzi M, Lapadula G, Cerinic MM, Montecucco C, Triolo G, Trotta F, Valentini G.
    Reumatismo; 2009 Jun 17; 61 Suppl 1():1-23. PubMed ID: 19999184
    [Abstract] [Full Text] [Related]

  • 12. The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept.
    Jamnitski A, Bartelds GM, Nurmohamed MT, van Schouwenburg PA, van Schaardenburg D, Stapel SO, Dijkmans BA, Aarden L, Wolbink GJ.
    Ann Rheum Dis; 2011 Feb 17; 70(2):284-8. PubMed ID: 21068090
    [Abstract] [Full Text] [Related]

  • 13. Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al.
    Francis S, Block MJ.
    Arthritis Rheum; 2010 Sep 17; 62(9):2826; author reply 2826-8. PubMed ID: 20556822
    [No Abstract] [Full Text] [Related]

  • 14. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A.
    JAMA; 2009 Feb 18; 301(7):737-44. PubMed ID: 19224750
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ, van de Putte LB, Breedveld FC.
    Ned Tijdschr Geneeskd; 2001 Sep 29; 145(39):1880-5. PubMed ID: 11605312
    [Abstract] [Full Text] [Related]

  • 16. [Anti-TNF alpha in rheumatoid arthritis].
    Schreiber S, Sternon J.
    Rev Med Brux; 2001 Jun 29; 22(3):174-80. PubMed ID: 11488086
    [Abstract] [Full Text] [Related]

  • 17. [New treatments for rheumatoid arthritis].
    Girault V, Flipo RM.
    Soins; 2004 Sep 29; (688):37-8. PubMed ID: 15515847
    [No Abstract] [Full Text] [Related]

  • 18. The yin and yang of tumor necrosis factor inhibitors.
    Calabrese L.
    Cleve Clin J Med; 2006 Mar 29; 73(3):251-6. PubMed ID: 16548447
    [Abstract] [Full Text] [Related]

  • 19. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
    Asahina A, Ishii N, Tohma S.
    J Dermatol; 2012 Feb 29; 39(2):199-201. PubMed ID: 21463364
    [No Abstract] [Full Text] [Related]

  • 20. Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study.
    Markatseli TE, Alamanos Y, Saougou I, Voulgari PV, Drosos AA.
    Clin Exp Rheumatol; 2012 Feb 29; 30(1):31-8. PubMed ID: 22153557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.